DJIA 17,195.42 221.11 1.30%
NASDAQ 4,566.14 16.91 0.37%
S&P 500 1,994.65 12.35 0.62%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

72.60 1.07 (1.50%)

REAL-TIME: Last trade at

Extended Hours: $73.28 $0.68 (0.94%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

AZN $72.60 1.50%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $72.02
Previous Close $71.53
Daily Range $71.98 - $72.76
52-Week Range $52.08 - $82.68
Market Cap $91.7B
P/E Ratio 35.06
Dividend (Yield) $1.80 (3.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,298,808
Average Daily Volume 2,337,814
Current FY EPS $4.45





AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website:

News & Commentary Rss Feed

5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know

Bristol-Myers Squibb reported third-quarter earnings last week. Here are five things management wants investors to know.

Update: AstraZeneca Wins FDA Approval For Xigduo XR, Shares Rise

5 Things GlaxoSmithKline plc Stock's Management Wants You to Know

GlaxoSmithKline held its third-quarter conference call last week. Here's what the company's management wants you to know.

Sector Update: Health Stocks Mixed Pre-Bell

Sector Update: Health Care

Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success

How To Protect Your Portfolio With Low-Volatility Stocks

Pfizer Beats Earnings, But Lacks Year-over-Year EPS Growth - Stocks in the News

Theravance: 2 Hidden Catalysts Will Boost Sales

AstraZeneca's Lynparza a Step Closer to European Approval - Analyst Blog

See More AZN News...

AZN's Top Competitors

AZN $72.60 (1.50%)
Current stock: AZN
JNJ $107.04 (1.40%)
Current stock: JNJ
NVS $91.95 (0.70%)
Current stock: NVS
RHHBY $37.18 (1.23%)
Current stock: RHHBY